Alyeska Investment Group, L.P. Genocea Biosciences, Inc. Call Options Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.06 $498,861 - $919,588	-300,519 Reduced 20.07%	1,196,981 $2.75 Million
Q1 2020 May 15, 2020	SELL	$1.26 - $2.73 $3,150 - $6,825	-2,500 Reduced 0.17%	1,497,500 $2.58 Million
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $5.21 Million - $10.1 Million	1,500,000 New	1,500,000 $0

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.